Scout Investments Inc. purchased a new stake in Illumina, Inc. (NASDAQ:ILMN) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 73,448 shares of the life sciences company’s stock, valued at approximately $14,631,000. Scout Investments Inc. owned approximately 50,306.85% of Illumina as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in ILMN. Dupont Capital Management Corp acquired a new position in shares of Illumina during the 3rd quarter worth approximately $153,000. Advisory Services Network LLC boosted its holdings in shares of Illumina by 13.0% during the 2nd quarter. Advisory Services Network LLC now owns 772 shares of the life sciences company’s stock worth $134,000 after purchasing an additional 89 shares during the last quarter. Penserra Capital Management LLC boosted its holdings in shares of Illumina by 13.0% during the 2nd quarter. Penserra Capital Management LLC now owns 884 shares of the life sciences company’s stock worth $153,000 after purchasing an additional 102 shares during the last quarter. Paradigm Asset Management Co. LLC boosted its holdings in shares of Illumina by 5.6% during the 2nd quarter. Paradigm Asset Management Co. LLC now owns 950 shares of the life sciences company’s stock worth $165,000 after purchasing an additional 50 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. boosted its holdings in shares of Illumina by 11.3% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 985 shares of the life sciences company’s stock worth $171,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 93.07% of the company’s stock.

ILMN has been the topic of several recent research reports. Leerink Swann restated an “outperform” rating and set a $225.00 target price (up from $207.00) on shares of Illumina in a report on Tuesday, September 12th. Piper Jaffray Companies restated an “overweight” rating and set a $226.00 target price (up from $202.00) on shares of Illumina in a report on Monday, October 9th. Janney Montgomery Scott upgraded Illumina from a “sell” rating to a “neutral” rating in a report on Monday, October 23rd. Citigroup Inc. upped their price objective on Illumina from $180.00 to $220.00 and gave the company a “neutral” rating in a report on Wednesday, October 25th. Finally, Bank of America Corporation upped their price objective on Illumina from $215.00 to $240.00 and gave the company a “buy” rating in a report on Wednesday, October 25th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $200.88.

In related news, SVP Charles Dadswell sold 145 shares of the stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $205.71, for a total transaction of $29,827.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jay T. Flatley sold 20,000 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $194.73, for a total transaction of $3,894,600.00. Following the transaction, the director now directly owns 539,176 shares of the company’s stock, valued at $104,993,742.48. The disclosure for this sale can be found here. Insiders have sold 187,964 shares of company stock valued at $38,454,069 in the last quarter. Insiders own 1.60% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Scout Investments Inc. Purchases New Position in Illumina, Inc. (ILMN)” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/scout-investments-inc-purchases-new-position-in-illumina-inc-ilmn/1695418.html.

Illumina, Inc. (ILMN) opened at $208.94 on Friday. The company has a quick ratio of 3.73, a current ratio of 4.22 and a debt-to-equity ratio of 0.41. Illumina, Inc. has a 12 month low of $119.37 and a 12 month high of $214.50. The stock has a market cap of $30,603.06, a price-to-earnings ratio of 61.29, a price-to-earnings-growth ratio of 3.46 and a beta of 0.74.

Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, October 24th. The life sciences company reported $1.11 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.12. Illumina had a net margin of 30.34% and a return on equity of 19.42%. The business had revenue of $714.00 million during the quarter, compared to the consensus estimate of $692.77 million. During the same quarter in the prior year, the firm earned $0.97 earnings per share. The business’s quarterly revenue was up 17.6% compared to the same quarter last year. equities research analysts forecast that Illumina, Inc. will post 3.75 EPS for the current fiscal year.

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.